Corrigendum: Microfluidic-based human prostate-cancer-on-chip

Linan Jiang; Hunain Khawaja; Shekha Tahsin; Tanjia A Clarkson; Cindy K Miranti; Yitshak Zohar

doi:10.3389/fbioe.2024.1520130

Corrigendum: Microfluidic-based human prostate-cancer-on-chip

Front Bioeng Biotechnol. 2024 Nov 12:12:1520130. doi: 10.3389/fbioe.2024.1520130. eCollection 2024.

Authors

Linan Jiang¹, Hunain Khawaja², Shekha Tahsin², Tanjia A Clarkson³, Cindy K Miranti^{4

5}, Yitshak Zohar^{1

5}

Affiliations

¹ Department of Aerospace and Mechanical Engineering, Tucson, AZ, United States.
² Cancer Biology Graduate Interdisciplinary Program, Tucson, AZ, United States.
³ College of Sciences, Tucson, AZ, United States.
⁴ Department of Molecular and Cellular Biology, Tucson, AZ, United States.
⁵ University of Arizona Cancer Center, University of Arizona, Tucson, AZ, United States.

Abstract

[This corrects the article DOI: 10.3389/fbioe.2024.1302223.].

Keywords: cancer-associated fibroblasts (CAFs); microfluidics; organ-on-chip; prostate cancer; prostate tumor invasion; stromal fibroblasts; tumor microenvironment.

Publication types

Published Erratum

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. LJ, HK, ST, TC, CM, and YZ were supported by funding from NIH/NCI MPI R01 CA254200 as part of the Tissue Engineering Consortium and TACMASR by P30 CA023075 UACC support grant. TC acknowledges partial support by the NIH/NCI U54CA143924 for the Partnership of Native American Cancer Prevention (NACP). ST acknowledges support by NIH/NCI T32 CA009213.